Drug Profile
Methoxy polyethylene glycol-epoetin beta biosimilar - Intas Biopharmaceuticals
Alternative Names: Peg EPOLatest Information Update: 20 Apr 2022
Price :
$50
*
At a glance
- Originator Intas Biopharmaceuticals
- Class Antianaemics; Colony-stimulating factors; Erythropoietins; Haematopoietic cell growth factors; Polyethylene glycols
- Mechanism of Action Erythropoiesis stimulants; Erythropoietin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Anaemia
Most Recent Events
- 20 Apr 2022 No development reported - Phase-III for Anaemia in India (SC)
- 28 Jul 2018 No recent reports of development identified for clinical-Phase-Unknown development in Anaemia in India (SC, Injection)
- 04 Nov 2013 Clinical trials in Anaemia in India (SC)